#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Huntington's disease Pyruvate dehydrogenase complex deficiency Nephropathy MELAS syndrome Juvenile psoriatic arthritis Marginal zone lymphoma Ewing's sarcoma Cystic fibrosis respiratory infection suppression Shprintzen-Goldberg syndrome PIK3CA-activated mutation Chondrosarcoma Enteritis Polymyositis Hairy cell leukaemia recurrent Carcinoid syndrome More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic – Life with Disease Proteus syndrome – Diagnostics CADASIL Burkitt’s lymphoma – Life with Disease Stevens-Johnson syndrome – Treatment Noonan syndrome – Diagnostics Proteus syndrome – Trials in Disease Leiomyosarcoma – Basic Information Haemophilia B with anti factor IX – Basic Information Mantle cell lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MB-HUCART19.1 Alx148 Flecainide Ceritinib Bezafibrate Padeliporfin Thiocolchicoside BMS-986365 Bio89-100 TETANUS TOXOID Esketamine Ciclesonide Sacubitril GOLD SODIUM THIOSULFATE Heparin Mitazalimab Sym024 Pentosan Polysulfate Sodium Milrinone AZD4512 More therapies…

    Learn about Your Condition

    Multiple system atrophy Thrombocytosis Ovarian cancer metastatic Craniosynostosis Tonsillitis Tricuspid valve disease Myofascial pain syndrome Albright's disease Neuromyopathy Giant cell arteritis Pulmonary congestion Liver transplant Hypoaesthesia Crigler-Najjar syndrome Rubella More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Myelodysplastic syndrome

  • Study of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Thiotepa
    • Busulfan
    • Fludarabine Phosphate
    Italy

  • Study of Elritercept for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes (MDS)

    Recruiting

    2 1 1
    Investigated Drugs:
    • Elritercept
    Czechia France Germany Spain

  • Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

    Recruiting

    2 1 1
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    Austria Bulgaria Germany Hungary Poland Romania +2

  • Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thalassaemia
    • Primary myelofibrosis
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Luspatercept
    Bulgaria France Germany Greece Italy The Netherlands +2

  • Study on Azacitidine for Patients with Myelodysplastic Syndrome After Stem Cell Transplantation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Azacitidine
    Denmark Finland Norway Sweden

  • Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Ciclosporin
    • Treosulfan
    Belgium France
Previous Page
1 2 3 4 5 6 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!